Literature DB >> 3756795

Hodgkin's disease presenting with isolated craniospinal involvement.

B L Bender, D G Mayernik.   

Abstract

A 34-year-old man presented with tumor of his cervical spinal meninges and bone and the dura over the right frontal lobe, which was shown on biopsy to be Hodgkin's lymphoma. Extensive noninvasive evaluation failed to reveal any other sites of disease. Central nervous system involvement with Hodgkin's disease is extremely rare and is almost always a late complication in patients who have widely disseminated disease in the usual nodal sites. The current patient is unique in that his initial symptoms were due to involvement of the central nervous system and he had no evidence of Hodgkin's disease elsewhere.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3756795     DOI: 10.1002/1097-0142(19861015)58:8<1745::aid-cncr2820580827>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

Review 1.  Meningeal metastases: clinical aspects and diagnosis.

Authors:  F Formaglio; A Caraceni
Journal:  Ital J Neurol Sci       Date:  1998-06

Review 2.  Recognizing unusual manifestations of Hodgkin lymphoma.

Authors:  Nicholas A Barber; Philip J Bierman
Journal:  Curr Hematol Malig Rep       Date:  2012-09       Impact factor: 3.952

3.  Simultaneous Occurrence of Hodgkin's Lymphoma and Langerhans Cell Histiocytosis of the Spine : A Rare Combination.

Authors:  Seung-Jae Hyun; Seung-Chul Rhim; Jooryung Huh
Journal:  J Korean Neurosurg Soc       Date:  2010-04-30

4.  A case of Vogt-Koyanagi-Harada syndrome in a patient affected by Hodgkin's disease.

Authors:  D Cipriani; G Landonio; C Canepari
Journal:  J Neurol       Date:  1989-07       Impact factor: 4.849

5.  Intracerebral manifestation of iatrogenic, immunodeficiency-associated polymorphic B-LPD with morphology mimicking Hodgkin lymphoma: a case report and literature review.

Authors:  Leonie Saft; Marina Perdiki-Grigoriadi; Georgios Rassidakis
Journal:  J Hematop       Date:  2022-03-04       Impact factor: 0.625

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.